| Accession |
PRJCA015674 |
| Title |
Preclinical and phase Ia/Ib study of of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blockade, in patients with advanced solid tumors |
| Relevance |
Medical |
| Data types |
PK/ADA
|
| Organisms |
Homo sapiens
|
| Description |
Preclinical and phase Ia/Ib study of of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blockade, in patients with advanced solid tumors |
| Sample scope |
Homo sapiens |
| Release date |
2023-03-21 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Qilu Pharmaceutical Co., Ltd
|
|
NA
|
|
|
|
| Submitter |
panpan
ma (panpan.ma@qilu-pharma.com)
|
| Organization |
Qilu Pharmaceutical Co., Ltd |
| Submission date |
2023-03-21 |
